Biotechnology and data intelligence converge once again in a groundbreaking development. 💡 The Spanish company Foreomics has created a scientific tool that could redefine preventive medicine by detecting mortality risks and serious diseases in individuals who appear to be healthy.
🧠Integrated science, technology, and data
Led by Jorge García and Dr. Eliseo Vañó (radiologist at Hospital Nuestra Señora del Rosario), the initiative uses a multidimensional methodology that combines:
- 🧬 Genetic data
- 🩸 Clinical analyses and saliva samples
- 💻 A digital lifestyle and habits questionnaire
- 🩻 Low-dose CT imaging
In less than 30 minutes, the system gathers all this information, processes it through a retrospective algorithm, and generates a visual report with color codes, personalized metrics, and medical recommendations tailored to each person.
⚕️Prediction and prevention in a single tool
Beyond indicating risk levels for various causes of mortality, the system provides preventive suggestions and customized follow-up plans, bringing medicine closer to a truly proactive and predictive model.
Foreomics states that its model has been trained on thousands of real cases and clinical evidence, supported by a multidisciplinary panel of experts in cardiology, oncology, radiology, and genetics, including José Luis Zamorano, Julio Mayol, Pablo Lapunzina, and Mariano Provencio.
💶 Innovation with global potential
With a pre-money valuation of €20 million, Foreomics reflects the growing market interest in predictive health analytics.
The company plans to launch in Spain in 2026, followed by expansion into Latin America, the United States, and Europe between 2027 and 2028—an ambitious roadmap that could reshape early-diagnosis systems worldwide. 🌍
🚀 A step toward the future of medicine
If clinical validations confirm its effectiveness, Foreomics could mark the beginning of a new era in preventive care—one where data, artificial intelligence, and biotechnology work together to anticipate diseases before symptoms appear.
